Novartis AG NVSEF
162.12 USD +1.47 (+0.92%)
At closeNov 11, 2026, 4:00 PM EST
136.10 Day range 136.10
123.69 52-week range 171.29
- YTD
- +17.48%
- 1 year
- +28.34%
News
seekingalpha.com Novartis: Q3 2026 Earnings Confirm 'Hold' Recommendation Based On Balanced Approach Novartis is rated Hold, with a 12-month price target of $141.81, implying a 12.0% downside from the current share price. My model indicates near-term pressure on selected products, while projected…
seekingalpha.com Novartis: The Sell-Off Creates An Attractive Entry Point On October 27, Novartis will report its results for the third quarter. As a reminder, its Q2 revenue rose 10.6% quarter-over-quarter to $14.95 billion, primarily due to the strong performance of the…
seekingalpha.com How To Build A $50,000 Dividend Portfolio In Today's Market The Dividend Income Accelerator Portfolio emphasizes high-quality companies with sustainable dividends, strong balance sheets, and attractive valuations to optimize risk-adjusted returns. I…
globenewswire.com New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer Basel, May 17, 2026 – Novartis today announced new data from PSMAddition demonstrating improved prostate-specific antigen (PSA) responses with Pluvicto® (lutetium (177Lu) vipivotide tetraxetan)…
benzinga.com Stocks That Hit 52-Week Highs On Wednesday 
benzinga.com Stocks That Hit 52-Week Highs On Wednesday 
benzinga.com Stocks That Hit 52-Week Highs On Friday 
benzinga.com Stocks That Hit 52-Week Highs On Friday - benzinga.com Stocks That Hit 52-Week Highs On Thursday
- benzinga.com Stocks that Broke 52-Week Highs Tuesday